We are live on
!
Find out more
SC
Stralem & Co Portfolio holdings
AUM
$157M
1-Year Est. Return
4.29%
This Fund
S&P 500
This Quarter
Est. Return
+0.22%
1 Year Est. Return
+4.29%
3 Year Est. Return
+25.48%
5 Year Est. Return
+55.56%
10 Year Est. Return
–
AUM
$1.79B
AUM Growth
-$362M
(-17%)
Cap. Flow
-$354M
Cap. Flow
% of AUM
-19.74%
Top 10 Holdings %
Top 10 Hldgs %
32.65%
Holding
57
New
5
Increased
2
Reduced
40
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson Controls International
JCI
|
+$56.2M |
| 2 |
CVS Health
CVS
|
+$54.2M |
| 3 |
UnitedHealth
UNH
|
+$53.9M |
| 4 |
Lowe's Companies
LOW
|
+$53M |
| 5 |
Johnson & Johnson
JNJ
|
+$36.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$88M |
| 2 |
Eaton
ETN
|
+$73.6M |
| 3 |
Visa
V
|
+$36.3M |
| 4 |
Walt Disney
DIS
|
+$33.5M |
| 5 |
Starbucks
SBUX
|
+$33.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.93% |
| 2 | Industrials | 12.29% |
| 3 | Energy | 12.26% |
| 4 | Communication Services | 11.55% |
| 5 | Utilities | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Pfizer
PFE
$150B
| $62.4M | 3.48% |
1,890,469
-345,455
| -15% | -$11M |
|
|
2
Starbucks
SBUX
$124B
| $61.2M | 3.42% |
1,291,800
-744,622
| -37% | -$33.5M |
|
3
DuPont de Nemours
DD
$19.5B
| $60.3M | 3.37% |
496,416
-156,310
| -24% | -$18.5M |
|
|
4
UnitedHealth
UNH
$364B
| $58.9M | 3.29% |
497,900
+485,200
| +3,820% | +$53.9M |
|
|
PPL
5
PPL Corp
PPL
$26.7B
| $58.8M | 3.28% |
1,874,465
-246,158
| -12% | -$7.91M |
|
|
6
Johnson Controls International
JCI
$92.6B
| $58.4M | 3.26% |
+1,106,415
| New | +$56.2M |
|
|
7
Walt Disney
DIS
$178B
| $56.3M | 3.14% |
536,439
-332,338
| -38% | -$33.5M |
|
8
Dominion Energy
D
$59.8B
| $56.2M | 3.14% |
792,480
-114,625
| -13% | -$8.5M |
|
9
Danaher
DHR
$145B
| $56.1M | 3.13% |
983,777
-521,015
| -35% | -$29.9M |
|
10
Southern Company
SO
$106B
| $56.1M | 3.13% |
1,266,945
-161,959
| -11% | -$7.69M |
|
|
11
CVS Health
CVS
$121B
| $55.3M | 3.09% |
+535,750
| New | +$54.2M |
|
12
GE Aerospace
GE
$379B
| $55.3M | 3.09% |
464,819
-129,000
| -22% | -$15.4M |
|
|
13
Lowe's Companies
LOW
$121B
| $55M | 3.07% |
+739,900
| New | +$53M |
|
14
Coca-Cola
KO
$373B
| $54.9M | 3.07% |
1,354,046
-184,310
| -12% | -$7.71M |
|
15
Merck
MRK
$328B
| $54.2M | 3.02% |
987,342
-155,712
| -14% | -$8.82M |
|
16
AT&T
T
$166B
| $53.8M | 3% |
2,181,401
-313,624
| -13% | -$7.97M |
|
17
RTX Corp
RTX
$300B
| $53.8M | 3% |
729,308
-380,437
| -34% | -$28.4M |
|
|
18
Visa
V
$671B
| $53.8M | 3% |
821,924
-549,308
| -40% | -$36.3M |
|
19
Warner Bros
WBD
$69.3B
| $51.8M | 2.9% |
1,685,400
-268,316
| -14% | -$8.42M |
|
20
SLB Ltd
SLB
$78.1B
| $51.2M | 2.86% |
614,194
-132,535
| -18% | -$11M |
|
21
FedEx
FDX
$77.3B
| $50.9M | 2.84% |
307,899
-184,367
| -37% | -$32M |
|
22
Oracle
ORCL
$442B
| $49.4M | 2.76% |
1,143,877
-173,491
| -13% | -$7.52M |
|
23
Philip Morris
PM
$290B
| $47.5M | 2.65% |
630,212
-75,024
| -11% | -$6.09M |
|
24
Microsoft
MSFT
$3.66T
| $45.6M | 2.55% |
1,121,411
-131,970
| -11% | -$5.75M |
|
25
Alphabet (Google) Class C
GOOG
$4.19T
| $45M | 2.51% |
1,627,396
-264,023
| -14% | -$7.08M |
|
Similar funds
LI
BC
JT
SCM
HF
SMFS
CCM
CCM
Stralem & Co's Q1 2015 Portfolio in Review
As of Q1 2015, Stralem & Co held 57 positions worth $1.79B, down 17% from $2.15B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Stralem & Co withdrew a net $354M in Q1 2015, closing 3 positions and reducing 40 holdings. Its most notable exit was Du Pont De Nemours E I, an estimated $88M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 21% a quarter earlier, followed by Industrials and Energy.
Against the trend, Stralem & Co opened a new position in Johnson Controls International worth $58.4M.
- Stralem & Co's largest Q1 2015 buy was Johnson Controls International: 1,106,415 shares worth $58.4M.
- Stralem & Co added most to UnitedHealth in Q1 2015, an estimated $53.9M increase.
- Stralem & Co's biggest Q1 2015 reduction was Visa, cutting an estimated $36.3M.
- Stralem & Co fully exited Du Pont De Nemours E I in Q1 2015, selling an estimated $88M.
- Stralem & Co's ten largest holdings make up 33% of its $1.79B portfolio in Q1 2015.
- Stralem & Co opened 5 new positions and closed 3 in Q1 2015.
- Stralem & Co's portfolio value fell 17% quarter-over-quarter to $1.79B.
Based on Stralem & Co's 13F filing for Q1 2015, filed 16 Apr 2015.